Edition:
India

Aurora Cannabis Inc (ACB.TO)

ACB.TO on Toronto Stock Exchange

4.82CAD
23 Oct 2019
Change (% chg)

$0.13 (+2.77%)
Prev Close
$4.69
Open
$4.65
Day's High
$4.87
Day's Low
$4.59
Volume
6,248,589
Avg. Vol
4,907,580
52-wk High
$13.67
52-wk Low
$4.59

Summary

Name Age Since Current Position

Michael Singer

55 2019 Executive Chairman of the Board

Steve Dobler

55 2014 President, Director

Terry Booth

55 2014 Chief Executive Officer, Director

Glen Ibbott

2017 Chief Financial Officer

Allan Cleiren

2017 Chief Operational Officer

Debra Wilson

2018 Chief Human Resource Officer

Darryl Vleeming

2017 Chief Information Officer

Cameron Battley

2018 Chief Corporate Officer

Neil Belot

2017 Chief Global Business Development Officer

Darren Karasiuk

2019 Chief Commercial Officer

Jonathan Page

2018 Chief Science Officer

Jillian Swainson

2019 Chief Legal Officer, Corporate Secretary

Ronald Funk

62 2019 Lead Independent Director

Margaret Atkins

62 2019 Independent Director

Norma Beauchamp

58 2018 Independent Director

Jason Dyck

2015 Independent Director

Adam Szweras

47 2015 Independent Director

Ananth Krishnan

2019 Vice President, Capital Markets & Investor Relations

Biographies

Name Description

Michael Singer

Mr. Michael Singer is Executive Chairman of the Board of the Company. He has extensive financial management, capital markets and corporate governance experience in the pharmaceutical and medical cannabis industries. He formerly acted as the Chief Financial Officer of NASDAQ-listed Clementia Pharmaceuticals Inc., a Montreal based clinical stage biopharmaceutical company from May 2015 until July 2018. From May 2014 until June 2015, he was Chief Financial Officer of Bedrocan Cannabis Corp. Michael has held numerous independent director roles in Canadian public health care companies, and also previously served as CFO and Corporate Secretary for TSX-V listed Thallion Pharmaceuticals Inc. Michael holds a Graduate Diploma in Public Accounting from McGill University and a Bachelor of Commerce from Concordia University.

Steve Dobler

Mr. Steve Dobler is President, Director of the Company. Mr. Dobler has worked closely with Mr. Booth in the permitting space for over 20 years and was co-founder of the Company. Mr. Dobler holds a Bachelor of Science in Engineering from the University of Alberta and is a Professional Engineer with previous public company experience. He has held numerous executive positions in successful private and public Canadian companies over the past 25 years where he was responsible for the implementation of project management, strategies, and overseeing all facets of various operations. He has been involved in numerous private company acquisitions, integrations, operations and successful exits. Steve obtained his Bachelor of Science in Engineering from the University of Alberta in 1986 and is a Professional Engineer

Terry Booth

Mr. Terry Booth is Chief Executive Officer, Director of the Company. Mr. Booth co-founded the Company in 2013 when the Canadian federal government created a new regulatory regime for the national medical cannabis system. Investing $2.5 million of his own capital in start-up funding, he secured a 160-acre parcel of land in the foothills of the Rocky Mountains and designed and built the Company’s first advanced cannabis production facility, Aurora Mountain. Terry has assembled a diverse and highly skilled team of experts from a broad range of disciplines to execute on the Company’s business strategy and vision to build the world’s foremost cannabis company. Prior to founding the Company, Terry had been in the industrial permitting and governmental regulatory sector for over 20 years. Education: Terry received his Master Electrician designation from the Northern Alberta Institute of Technology (NAIT) in 1987.

Glen Ibbott

Mr. Glen Ibbott is a Chief Financial Officer of the Company. He is a seasoned senior health care executive with over 20 years of experience providing financial leadership to various public entities, including management of Canadian and international capital market strategies, mergers and acquisitions, and tax and finance, predominantly within the life sciences sector. An innovative, decisive and insightful professional, he has excelled in delivering revenue and profitability growth, both domestically and internationally, strategy execution and shareholder value creation, including key contributions to numerous corporate transactions. Most recently, Mr. Ibbott was CFO at QLT Inc, a Nasdaq Stock Market- and Toronto Stock Exchange-listed biopharmaceutical company, and played a key role in QLT's $500-million merger with Aegerion Pharmaceuticals to form Novelion Therapeutics. Prior to his time at QLT, Mr. Ibbott held various senior finance positions, including with globally operating companies such as Nordion, International Forest Products, Angiotech Pharmaceuticals, Aspreva Pharmaceuticals and Inex Pharmaceuticals. Earlier in his career, he worked within the technology practice of KPMG. Mr. Ibbott completed MBAs at Cornell University and at Queen's University, is a Canadian chartered professional accountant (CPA, CA), as well as a U.S. CPA, and holds a bachelor of business administration from Simon Fraser University.

Allan Cleiren

Mr. Allan Cleiren serves as Chief Operational Officer of the Company. He has nearly three decades of leadership experience in finance and operations management with both privately and publicly held companies in the life sciences, insurance, rail, construction, oil and gas service, and other sectors. Through various senior positions, he has held responsibility for all aspects of operations, including manufacturing, logistics, human resources, IT, and marketing. As a senior financial executive, Mr. Cleiren also has considerable experience in M&A and restructuring. Throughout his career, Mr. Cleiren's focus has been on achieving operational excellence and efficiency, contributing to significant revenue and profitability growth. Most recently, Mr. Cleiren was COO with Jardine Lloyd Thompson Canada Inc. (JLT), one of the world's leading providers of insurance, reinsurance and employee benefits related advice, brokerage and associated services. Prior to joining JLT, he served as Executive Vice President and formerly CFO for Universal Rail Systems Inc, and as Senior Vice President of Operations and CFO for Afexa Life Sciences. He is a member of the Board of Directors of Universal Rail Services Inc., Metalogic Inspection Services Inc., and is Chair of the Board for the Alberta Automobile Insurance Rate Board. Mr. Cleiren is a Chartered Professional Accountant (CPA, CA), holds a Bachelor of Commerce from the University of Alberta, and has a Diploma in Management Sciences from the Grant MacEwan College in Alberta. Mr. Cleiren also holds a ICD.D designation through the Institute of Corporate Directors.

Debra Wilson

Dr. Debra Wilson serves as Chief Human Resource Officer of the Company. Dr. Wilson joined the Company in June, 2017 and previously served as Vice President and Senior Vice President of Human Resources. She is a seasoned leader with more than 25 years' experience in human resources, developing and practicing leading edge methods. Debra earned her PhD in industrial and organizational psychology from Capella University, and her MBA from Royal Roads University, with a concentration in Human Resource Management. Believing strongly in professional development, Debra is also an adjunct instructor for courses in Human Resource at the Northern Alberta Institute of Technology (NAIT). Prior to joining Aurora, Debra was a leader in the areas of Human Resources and Organizational Development for various organizations across several industries. Debra was Director of Human Resources for Universal Rail Systems, a specialized rail construction and maintenance company with offices across Canada. Prior to that, Debra was Vice President of Human Resources and Organizational Development at Alberta Pensions Services Corporation, Senior Director of HR and Administration for Afexa Life Sciences, Vice President of Human Resources for Maclab Enterprises Inc. and Vice President of Human Resources for Bentall Kennedy.

Darryl Vleeming

Mr. Darryl Andrew Vleeming serves as Chief Information Officer of the Company. Mr. Vleeming comes to Aurora with over 20 years of experience in senior IT leadership, project delivery, and IT strategic planning at publicly traded international corporations, with a specific focus on driving business value. Prior to joining Aurora, Mr. Vleeming spent eight years, lastly as Vice President, IS and Chief Information Officer, at Capital Power Corporation, a $2.5 billion, TSX listed independent power producer. Among other responsibilities, Mr. Vleeming was in charge of the division running the corporation's mission critical IT systems, general IT asset management, as well as development of the corporation's strategic technology vision to drive competitive differentiation. Prior to Capital Power, Mr. Vleeming was Manager of Systems Development at EPCOR, one of Canada's top providers of energy and energy-related services and products in Alberta, Ontario, and the United States.

Cameron Battley

Mr. Cameron Battley serves as Chief Corporate Officer of the Company. Mr. Battley was Chief Corporate Officer of Aurora; Executive Vice-President of Aurora (March 2016 to January 2018); President at Health Strategy Group (December 1997 to March 2016).

Neil Belot

Mr. Neil Belot is Chief Global Business Development Officer of the Company. He was Chief Global Business Development Officer of Aurora; Chief Brand Officer at Aurora from September 8, 2015 to March 20, 2017; Executive Director of Canadian Medical Cannabis Industry Association from November 2014 to September 2015; Gas Portfolio & Energy Services Manager of Housing Services Corp. from September 2012 to September 2014.

Darren Karasiuk

Mr. Darren Anthony Karasiuk is Chief Commercial Officer of the company. He was Chief Commercial Officer of Aurora; former Senior Vice President, Recreational Marketing at MedReleaf; Associate at Marijuana Policy Group, LLC from October 2016 to March 2018; Vice President, Insights and Advisory at Deloitte Canada from August 2015 to October 2016; Vice President, Strategy at Environics Research Group Ltd. from 2011 to July 2015.

Jonathan Page

Dr. Jonathan Page Ph.D. is Chief Science Officer of the company. He is a Chief Science Officer of Aurora; CEO at Anandia Laboratories (January 2014 to October 2018).

Jillian Swainson

Ms. Jillian L. Swainson is Chief Legal Officer, Corporate Secretary of the Company. She was Senior Vice President, General Counsel of the Company. Ms. Swainson joins Aurora from Brownlee LLP, where she was a Partner in the law firm's business practice and where she handled a variety of business law matters, including corporate, commercial, intellectual property, and securities work. In addition to her general practice of business law, over the past several years she has developed an expertise in providing general counsel and advisory services to clients within the heavily regulated and increasingly complex cannabis industry. She graduated from the University of Alberta with a Bachelor of Commerce degree in 2004, and a law degree (LL.B.) in 2007. She joined Brownlee as an articling student in 2007, and was called to the bar in 2008. Ms. Swainson is also a Registered Trade-mark Agent.

Ronald Funk

Mr. Ronald Funk is Lead Independent Director of the Company. He was appointed a director of the Company on July 25, 2018. Mr. Funk brings over 30 years of experience in business and consulting to his role with the Company. Since 2009, he has managed his own consulting practice, working with clients on acquisitions, restructurings, strategy development and government relations. Mr. Funk has worked on projects in various locations around the world, with clients engaged in a range of industries, including heavily regulated consumer products such as tobacco, alcohol, and food products. Other industries in which he has consulted include retail, advanced data analytics, gaming, and real estate development. Before opening his consulting practice, Mr. Funk was employed for approximately 30 years by Rothmans, Benson & Hedges Inc., serving in various roles and capacities, including Vice President of Sales, Human Resources, Corporate Affairs and Competitive Improvement. In these senior roles, he developed and executed a number of strategies that resulted in material growth in both market share and profitability. Mr. Funk currently serves as an independent director of Carey Management Inc., a privately held business that owns Canada’s largest independent wholesale distributor. Mr. Funk has also served as the Chairman of the Ontario Convenience Stores Association and Treasurer of the Canadian Convenience Stores Association. Mr. Funk holds a Kellogg-Schulich MBA from the Kellogg School of Management and the Schulich School of Business.

Margaret Atkins

Ms. Margaret Shan Atkins CPA is Independent Director of the company. Margaret Shan brings over 20 years of corporate leadership experience to the Company. A Certified Public Accountant, she spent fourteen years at Bain & Company, where she became a partner and leader in the firm's global consumer and retail practice. She also maintained a secondary practice in healthcare, working in Rx and OTC pharmaceuticals and in the hospital industry. Margaret Shan also served as Executive VP of Sears, Roebuck & Company (USA) and since 1999, she has served as an independent director on ten public and private corporate boards in the U.S. and Canada. Education: Margaret Shan is a graduate of Queen's University where she obtained her B.Comm (hons) in 1979 and the Harvard Business School where she obtained her MBA in 1983.

Norma Beauchamp

Ms. Norma Beauchamp is Independent Director of the Company. She is also a director of Acerus Pharmaceuticals Corporation, Chair of their Corporate Governance and Nominating committee and a member of their Audit committee. Formerly, Ms. Beauchamp was a director, Chair of the Corporate Governance and Compensation committees and a member of the Audit Committee of MedReleaf, and Chief Executive Officer of Cystic Fibrosis Canada. Ms. Beauchamp brings over three decades of experience in the corporate and non-profit sectors to her role having held senior leadership positions in Canada and Germany, including executive positions at Bayer and Sanofi. Ms. Beauchamp has served on the Boards of St. Joseph’s Health Centre Foundation, Providence Healthcare Foundation and the Breast Cancer Society of Canada. Throughout her career, she has been a patient advocate, working with patient and healthcare organizations to enhance access to care. Norma has completed the University of Toronto’s Rotman School of Management Directors Education Program and obtained a Bachelor of Business Administration in Marketing from Bishop’s University in May 1983.

Jason Dyck

Dr. Jason R.B. Dyck Ph.D. is Independent Director of Aurora Cannabis Inc. Jason and is a distinguished research scientist in the Department of Pediatrics at the University of Alberta and currently directs the University of Alberta Cardiovascular Research Centre and co-directs the pan-Alberta program known as Alberta HEART. Not only is he an outstanding research scientist and a leader in his field but he also has extensive experience in drug discovery and commercialization. He co-founded a successful University of Alberta spin-off company, currently holds more than 100 patents and has numerous collaborations with large pharmaceutical companies. Education: Jason obtained his PhD from the University of Alberta in 1995.

Adam Szweras

Mr. Adam K. Szweras is Independent Director of the Company. Adam is a securities law partner with Fogler, Rubinoff LLP in Toronto and Chairman of the Foundation Markets Group, a Toronto based Merchant Bank and brokerage firm. Adam both joined Fogler, Rubinoff LLP and founded the Foundation Markets Group in 2006. His law practice focuses on financings and going public transactions, and in his banking practice, he works closely to build, invest in, and develop emerging business. Adam has a particular expertise with cross border mid-market transactions and often acts as a strategic advisor to his clients. Adam works with public and private companies active in cannabis markets in Canada and the US as well as companies with businesses in energy transmission, oil and gas and alternative energy, technology, and food producers. Adam has experience in representing clients in Canada and the US as well as South America, China and South Asia. In the spring of 2019, Adam accepted the CEO role with Nutritional High International, a US-focused cannabis distributor and edible and extract manufacturer, shifting from Co-Chairman of the Board. Education: Adam obtained his LLB from Osgoode Hall Law School in June 1994 and previously attended York University.

Ananth Krishnan

Basic Compensation